Oxford Health NHS Foundation Trust

I’m a psychiatrist, originally from Italy. During my training, I developed a significant interest in bipolar disorder and wanted to get more involved in research, so I decided to spend part of my training at the NIHR Clinical Research Facility (CRF): Oxford Health. I enjoyed the combination of research and patient care and ended up staying. Working in the Bipolar Disorder Res...

Oxford Health NHS Foundation Trust has launched its new strategy for 2026-2031, setting out its aims and priorities for the next five years. At its heart is the vision is to support every person to achieve their best quality of life. The strategy was shaped by input from patients, carers, families, colleagues and partner organisations. We want to thank everybody that took the...

Oxford’s involvement in the COMP006 study (psilocybin for depression) has reached an important milestone, with the final participant completing their last study visit. Delivered at the NIHR Clinical Research Facility (CRF): Oxford Health, COMP006 forms part of Compass Pathways’ international Phase 3 programme evaluating COMP360 psilocybin, administered alongside psychological...

Psychosis affects how people experience and interpret reality and can involve unusual beliefs and experiences, and difficulties with thinking and concentration. Although Early Detection mental health services can identify people who are at increased risk of psychosis, predicting which of these individuals will later develop the disorder remains a major clinical challenge.

The UK’s first Baseline Biomarker Check (BBC) clinic has been launched in Oxford, designed to improve the assessment of people experiencing first-episode psychosis. First-episode psychosis is the term used when a person experiences psychosis for the first time. People experiencing psychosis may see or hear things that others do not, known as hallucinations, or develop unusual...